Lpath (LPTN)

Add to Watchlists
Create an Alert
0.2349 +0.01  +4.08% NASDAQ May 5, 16:59 Delayed 2m USD
View Full Chart
LPTN Price Chart
View All Performance Charts

LPTN Total Returns Comparison

Advertisement

One Page Reports

Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • URL: http://www.lpath.com
  • Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=197881&p=irol-irhome
  • HQ Country: United States
  • HQ State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Nevada
  • Est. Current Fiscal Quarter End: June 30, 2016
  • Est. Current Fiscal Year End: December 31, 2016
  • Last Fiscal Quarter End: December 31, 2015
  • Last Fiscal Year End: December 31, 2015
  • Next Earnings Release: N/A
  • NAICS Name: Biological Product (Except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry Name: Pharmaceutical and Medicine Manufacturing
  • NAICS Sector Name: Manufacturing
  • Profile: Lpath Inc is a biotechnology company engaged in the discovery and development of lipidomic-based therapeutic antibodies to treat a wide range of human diseases. The Company's product candidates include iSONEP, ASONEP, Lpathomab, and ImmuneY2 Technology.

LPTN Comparables

Edit

LPTN Excel Add-In Codes

  • Name: =YCI("LPTN","name")
  • Description: =YCI("LPTN","description")
  • Sector: =YCI("LPTN","sector")
  • Industry: =YCI("LPTN","industry")
  • Est. Current Fiscal Year End: =YCI("LPTN","fye")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts.
Start your Free 7-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 7-Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.